193 References 1. Heemsbergen WD, Al-Mamgani A, Slot A, Dielwart MFH, Lebesque J V. Long-term results of the Dutch randomized prostate cancer trial: Impact of doseescalation on local, biochemical, clinical failure, and survival. Radiother Oncol 2014;110:104–9. 2. Beckendorf V, Guerif S, Le Prisé E, Cosset JM, Bougnoux A, Chauvet B, et al. 70 Gy versus 80 Gy in localised prostate cancer: 5-year results of GETUG 06 randomized trial. Int J Radiat Oncol Biol Phys 2011;80:1056–63. 3. Zumsteg ZS, Spratt DE, Romesser PB, Pei X, Zhang Z, Kollmeier M, et al. Anatomic Patterns of Recurrence Following Biochemical Relapse in the DoseEscalation Era for Prostate Patients Undergoing External Beam Radiotherapy. J Urol 2015;194:1624– 30. 4. Maenhout M, Peters M, van Vulpen M, Moerland MA, Meijer RP, van den Bosch MAAJ, et al. Focal MRIGuided Salvage High-Dose-Rate Brachytherapy in Patients With Radiorecurrent Prostate Cancer. Technol Cancer Res Treat 2017;16:1194–201. 5. Steele EM, Holmes JA. A review of salvage treatment options for disease progression after radiation therapy for localised prostate cancer. Urol Oncol Semin Orig Investig 2019;37:582–98. 6. Raaymakers BW, Jurgenliemk-Schulz IM, Bol GH, Glitzner M, Kotte ANTJ, van Asselen B, et al. First patients treated with a 1.5 T MRI-Linac: clinical proof of concept of a high-precision, high-field MRI guided radiotherapy treatment. Phys Med Biol 2017;62:L41– 50. 7. Lagendijk JJW, Raaymakers BW, van Vulpen M. The Magnetic Resonance Imaging–Linac System. Semin Radiat Oncol 2014;24:207–9. 8. de Muinck Keizer DM, Pathmanathan AU, Andreychenko A, Kerkmeijer LGW, van der Voort van Zyp JRN, Tree AC, et al. Fiducial marker based intrafraction motion assessment on cine-MR for MRLinac treatment of prostate cancer. Phys Med Biol 2019;64:07NT02. 9. Kontaxis C, Bol GH, Lagendijk JJW, Raaymakers BW. A new methodology for inter- and intrafraction plan adaptation for the MR-linac. Phys Med Biol 2015;60:7485–97. 10. Bol GH, Kotte ANTJ, van der Heide UA, Lagendijk JJW. Simultaneous multi-modality ROI delineation in clinical practice. Comput Methods Programs Biomed 2009;96:133–40. 11. de Muinck Keizer DM, Kerkmeijer LGW, Maspero M, Andreychenko A, van der Voort van Zyp JRN, et al. Soft-tissue prostate intrafraction motion tracking in 3D cine-MR for MR-guided radiotherapy. Phys Med Biol 2019;64:235008. 12. de Muinck Keizer DM, Kerkmeijer LGW, Willigenburg T, van Lier ALHMW, den Hartogh MD, van der Voort van Zyp JRN, et al. Prostate intrafraction motion during the preparation and delivery of MR-guided radiotherapy sessions. Radiother Oncol 2020;151:88– 94. 13. Kontaxis C, Bol GH, Stemkens B, Glitzner M, Prins FM, Kerkmeijer LGW, et al. Towards fast online intrafraction replanning for free-breathing stereotactic body radiation therapy with the MRlinac. Phys Med Biol 2017;62:7233–48. 14. Kontaxis C, Bol GH, Lagendijk JJW, Raaymakers BW. DeepDose: towards a fast dose calculation engine for radiation therapy using deep learning. Phys Med Biol 2020;65:075013. 15. Woodings SJ, Bluemink JJ, de Vries JHW, Niatsetski Y, van Veelen B, Schillings J, et al. Beam characterisation of the 1.5 T MRI-linac. Phys Med Biol 2018;63:085015. 16. Henderson D, Tree A, van As N. Single Fraction External Beam Radiotherapy for Localised Prostate Cancer: a Planning Study. Clin Oncol 2017;29:e87. 17. Zilli T, Koustouvelis N, Miralbell R, Scorsetti M, Franzese C, D’Agostino GR, et al. ONE SHOT - single shot radiotherapy for localised prostate cancer: Study protocol of a single arm, multicenter phase I/II trial. Radiat Oncol 2018;13:166. 18. Zilli T, Franzese C, Bottero M, Giaj-Levra N, Förster R, Zwahlen D, et al. Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial. Radiother Oncol 2019;139:83–6. 19. van Son MJ, Peters M, Moerland MA, Lagendijk JJW, Eppinga WSC, Shah TT, et al. MRI-Guided Ultrafocal Salvage High-Dose-Rate Brachytherapy for Localised Radiorecurrent Prostate Cancer: Updated Results of 50 Patients. Int J Radiat Oncol 2020;107(1):126-135.. 20. Van Son M, Peters M, Moerland M, Kerkmeijer L, Lagendijk J, Van der Voort van Zyp J. Focal salvage treatment of radiorecurrent prostate cancer: A narrative review of current strategies and future perspectives. Cancers 2018;10:480. 9 Focal salvage radiotherapy for recurrent prostate cancer
RkJQdWJsaXNoZXIy MTk4NDMw